Australia's ImpediMed soars on Q4 contract sales jump
** ImpediMed IPD.AX soars as much as 19% to A$0.044, highest since late March ** Stock logs biggest intraday pct gain since April 28 ** Medical tech co reports Q4 total contract value at A$6.3 million, up 29% on quarter ** Stock sees most active session since June 11, with ~8.6 mln shares traded vs 30-day avg of 2.4 mln ** IPD last up 10.8%, trims YTD losses to 21.2% (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com;))